Allergic rhinitis as a systemic disease of respiratory tract
Allergic rhinitis affects nearly 500 million people in the world and is now considered not only to be a local catarrh of the nasal passages, but a chronic systemic respiratory disease. Proof of generalization of this process is the frequent coexistence of asthma and allergic rhinitis. In recognition...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2019-05-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6893 |
id |
doaj-aed0abb9005b46319c350b4ab29343e2 |
---|---|
record_format |
Article |
spelling |
doaj-aed0abb9005b46319c350b4ab29343e22020-11-25T00:12:42ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062019-05-019515516010.5281/zenodo.27416986136Allergic rhinitis as a systemic disease of respiratory tractEleni Jasiukiewicz0Anna Fabian-Danielewska1Patrycja Piątek2NZOZ Przychodnia Medycyny Rodzinnej, ul. Kadłubka 10-11, SzczecinPomorski Uniwersytet Medyczny w Szczecinie, Studium Doktoranckie Wydziału LekarskiegoPomorski Uniwersytet Medyczny w Szczecinie, Studium Doktoranckie Wydziału LekarskiegoAllergic rhinitis affects nearly 500 million people in the world and is now considered not only to be a local catarrh of the nasal passages, but a chronic systemic respiratory disease. Proof of generalization of this process is the frequent coexistence of asthma and allergic rhinitis. In recognition, the most important role is played by, first of all, a well-collected interview and physical examination. Treatment depends on the form of AR (periodic or chronic) and on the severity of symptoms (mild, moderate or severe). The first-line drugs are nasal glucocorticosteroids and second generation antihistamines. Appropriate treatment allows to reduce ailments and avoid complications, including upper (sinusitis, exudative otitis media, tonsillitis) and lower respiratory tract (bronchial hyperresponsiveness, bronchial asthma), which significantly reduce the quality of life of patients (QOL).http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6893allergyrhinitisasthmaatopic |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eleni Jasiukiewicz Anna Fabian-Danielewska Patrycja Piątek |
spellingShingle |
Eleni Jasiukiewicz Anna Fabian-Danielewska Patrycja Piątek Allergic rhinitis as a systemic disease of respiratory tract Journal of Education, Health and Sport allergy rhinitis asthma atopic |
author_facet |
Eleni Jasiukiewicz Anna Fabian-Danielewska Patrycja Piątek |
author_sort |
Eleni Jasiukiewicz |
title |
Allergic rhinitis as a systemic disease of respiratory tract |
title_short |
Allergic rhinitis as a systemic disease of respiratory tract |
title_full |
Allergic rhinitis as a systemic disease of respiratory tract |
title_fullStr |
Allergic rhinitis as a systemic disease of respiratory tract |
title_full_unstemmed |
Allergic rhinitis as a systemic disease of respiratory tract |
title_sort |
allergic rhinitis as a systemic disease of respiratory tract |
publisher |
Kazimierz Wielki University |
series |
Journal of Education, Health and Sport |
issn |
2391-8306 |
publishDate |
2019-05-01 |
description |
Allergic rhinitis affects nearly 500 million people in the world and is now considered not only to be a local catarrh of the nasal passages, but a chronic systemic respiratory disease. Proof of generalization of this process is the frequent coexistence of asthma and allergic rhinitis. In recognition, the most important role is played by, first of all, a well-collected interview and physical examination. Treatment depends on the form of AR (periodic or chronic) and on the severity of symptoms (mild, moderate or severe). The first-line drugs are nasal glucocorticosteroids and second generation antihistamines. Appropriate treatment allows to reduce ailments and avoid complications, including upper (sinusitis, exudative otitis media, tonsillitis) and lower respiratory tract (bronchial hyperresponsiveness, bronchial asthma), which significantly reduce the quality of life of patients (QOL). |
topic |
allergy rhinitis asthma atopic |
url |
http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6893 |
work_keys_str_mv |
AT elenijasiukiewicz allergicrhinitisasasystemicdiseaseofrespiratorytract AT annafabiandanielewska allergicrhinitisasasystemicdiseaseofrespiratorytract AT patrycjapiatek allergicrhinitisasasystemicdiseaseofrespiratorytract |
_version_ |
1725397956978278400 |